| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |